In general, permanently high c-Myc activity is advantageous for cancer development, whereas its inactivation results in cancer suppression, and thus, elimination of c-Myc activity can be a potential method in anticancer therapy (Niu et al. 2015). The gene discussed is MYC; the disease is cancer.